Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

139 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q1 2024.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 66.9M shares of 84.8M outstanding shares and own 78.94% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.32M shares), NEA Management Company, LLC (5.11M shares), WELLINGTON MANAGEMENT GROUP LLP (3.91M shares), PERCEPTIVE ADVISORS LLC (3.76M shares), Vivo Capital, LLC (3.61M shares), ORBIMED ADVISORS LLC (3.4M shares), Deep Track Capital, LP (3.19M shares), Frazier Life Sciences Management, L.P. (3.01M shares), Carlyle Group Inc. (2.46M shares), and Octagon Capital Advisors LP (2.37M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.